Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations

Journal of Clinical Pathology

Volumn 59, Issue 12, 2006, Pages 1320-1326

  Mehraein, Y ^a   Wagner, M ^a   Remberger, K ^a   Fuzesi L ^b   Middel, P ^b   Kaptur, S ^a   Schmitt, K ^a   Meese, E ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CELL TYPE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NASAL BIOPSY; PARVOVIRUS; PARVOVIRUS INFECTION; PRIORITY JOURNAL; ROSAI DORFMAN DISEASE; SEROLOGY; SURGICAL TECHNIQUE; VIRUS DETECTION; VIRUS IDENTIFICATION;

ADULT; AGED; CAPSID PROTEINS; FEMALE; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPH NODES; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 33846007243     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.029850     Document Type: Article

References (30)

1. Rosai J, Dorfman RT. Sinus histiocytosis with massive lymphadenopathy; a newly recognized benign clinicopathological entity. Arch Pathol 1969;87:63-70.
2. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7:19-73.
3. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program) 2004:238-96.
4. Eisen RN, Buckley PJ, Rosai J. Immunopnenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diogn Pathol 1990;7:74-82.
5. Paulli M, Rosso R, Kindl S, et al. Immunophenotyic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol 1992;23:647-54.
6. Grabczynska SA, Toh CT, Francis N, et al. Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. Br J Dermatol 2001;145:323-6.
7. Levine PH, Jahan N, Murari P, et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992;166:291-5.
8. Luppi M, Borozzi P, Garber R, et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol 1998;153:815-23.
9. Tsang WY, Yip TT, Chan JK. The Rosai-Dorfman disease histiocytes are not infected by Epstein-Barr virus. Histopathology 1994;25:88-90.
10. Anderson MJ, Lewis E, Kidds IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984;93:85-93.
11. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-7.
12. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal bone marrow. J Virol 1988;62:3059-63.
13. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988;25:159-72.
14. Tolfvenstam T, Papadogiannakis N, Norbeck O, et al. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357:1494-7.
15. White DG, Woolf AD, Mortimer PP, et al. Human parvovirus arthropathy Lancet 1985;1:419-21.
16. Mitchell LA. Parvovirus B19 Nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol 2002;67:267- 74.
17. de la Rubia J, Moscardo F, Arriaga F, et al. Acute parvovirus B19 infection as a cause of autoimmune hemolytic anemia. Haematologica 2000;85:995-7.
18. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003;2;218-23.
19. Mehraein Y, Lennerz C, Ehlhardt S, et al. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol 2003;16:811-7.
20. Middel P, Hemmerlein B, Fayyazi A, et al. Sinus histiocytosis with massive iymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology 1999;35:525-33.
21. Shade RO, Blundell MC, Cotmore SF, et al. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
22. Cotmore SF, McKie VC, Anderson LJ, et al. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 1986;60:548-57.
23. Mehraein Y, Rehder H, Draeger HG, et al. Die Diagnostik fetaler Virusinfektionen durch in-situ-Hybridisierung, Geburtshilfe Frauenheilkd 1991;51:984-9.
24. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000;59:72-83.
25. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995;172:1198-205.
26. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003;2:218-23.
27. Uike N, Miyamura T, Obama K, et al. Parvovirus B19-associated haemophagocytosis in Evans-Syndrome: aplastic crisis accompanied by severe thrombocytopenia. Br J Haematol 1993;84:530-2.
28. Teochy DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 2005;105:2443-8.
29. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003;10:124-33.
30. Marie I, Pittaluga S, Dale J, et al. Sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Mod Pathol 2004;17:258A.